Muciclar

Active principle

Ambroxolo

Therapeutic class

Secretolytic therapy in acute and chronic bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport.

Package

• 15 mg/2 ml solution for inhalation – 30 units
• 30 mg granulate oral solution – 30 sachets
• 0,3% Syrup – 200 ml bottle
• 75 mg slow-release capsules – 20 caps

Reimbursement class

SOP

ATC code

R05CB06